SNOA Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals, Inc. (SNOA) is expected to report earnings on November 5, 2026, before the market open.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus Innovative Sciences and is headquatered in Petaluma, California.
Sector
Healthcare